Doctors seek best chemo for aggressive breast cancer
NCT ID NCT02688803
Summary
This study aimed to compare three standard chemotherapy treatments for triple-negative breast cancer, an aggressive form that doesn't respond to hormone therapies. Researchers wanted to test a new consent approach while determining which chemotherapy regimen works best for patients. The trial was designed to help doctors choose between existing standard treatments when there's no clear 'best' option available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, K2H 8L6, Canada
Conditions
Explore the condition pages connected to this study.